NEW YORK (GenomeWeb) – Foundation Medicine said today that it has received approval from the New York State Clinical Laboratory Evaluation Program for its FoundationACT blood-based circulating tumor DNA assay. All of its genomic profiling tests are now available in all 50 states, the company said.

To read the full story....

Register for Free.

...and receive Daily News bulletins.

Already have a 360Dx or GenomeWeb account?
Login Now.